These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32430749)

  • 21. ASO Author Reflections: Current Issues in Conduct and Reporting of Noninferiority Randomized Controlled Trials in the Surgical Management of Cancer Patients.
    Marini W; Moher D; McCready D; Parsyan A
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):751-752. PubMed ID: 32436188
    [No Abstract]   [Full Text] [Related]  

  • 22. Unresolved issues with noninferiority pragmatic trials: Results of a literature survey.
    Ciarleglio MM; Li J; Peduzzi P
    Clin Trials; 2024 Apr; 21(2):242-256. PubMed ID: 37927102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the Merits and Drawbacks of Noninferiority Trials in Cardiovascular Medicine.
    Kaul S
    Can J Cardiol; 2021 Sep; 37(9):1378-1393. PubMed ID: 34118378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methodological quality of oncology noninferiority clinical trials.
    Wayant C; Ross A; Vassar M
    Crit Rev Oncol Hematol; 2020 May; 149():102938. PubMed ID: 32172223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-sectional study of the reporting quality of pilot or feasibility trials in high-impact anesthesia journals.
    Shanthanna H; Kaushal A; Mbuagbaw L; Couban R; Busse J; Thabane L
    Can J Anaesth; 2018 Nov; 65(11):1180-1195. PubMed ID: 30094613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THE REPORTING QUALITY OF NONINFERIORITY TRIALS USING INTRAVITREAL VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS.
    Jia H; Li T; Wan H; Wu Z; Sun X
    Retina; 2023 Feb; 43(2):243-253. PubMed ID: 36695797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review.
    Strech D; Soltmann B; Weikert B; Bauer M; Pfennig A
    J Clin Psychiatry; 2011 Sep; 72(9):1214-21. PubMed ID: 21294992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review.
    Wangge G; Klungel OH; Roes KC; de Boer A; Hoes AW; Knol MJ
    PLoS One; 2010 Oct; 5(10):e13550. PubMed ID: 21048948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The characteristics and quality of randomized controlled trials in neuropathic pain: a descriptive study based on a systematic review.
    Sauzet O; Williams JE; Ross J; Branford R; Farquhar-Smith P; Griffith GL; Fox-Rushby JA; Peacock JL
    Clin J Pain; 2013 Jul; 29(7):591-9. PubMed ID: 23042476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Has CONSORT improved the reporting of randomized controlled trials in the palliative care literature? A systematic review.
    Piggott M; McGee H; Feuer D
    Palliat Med; 2004 Jan; 18(1):32-8. PubMed ID: 14982205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?
    Mansouri A; Cooper B; Shin SM; Kondziolka D
    J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the Details.
    Hussain M; Tangen C; Higano C; Vogelzang N; Thompson I
    J Clin Oncol; 2016 Jan; 34(3):280-5. PubMed ID: 26552421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CONSORT compliance in surgical randomized trials: are we there yet? A systematic review.
    Adie S; Harris IA; Naylor JM; Mittal R
    Ann Surg; 2013 Dec; 258(6):872-8. PubMed ID: 23732263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review.
    Péron J; Pond GR; Gan HK; Chen EX; Almufti R; Maillet D; You B
    J Natl Cancer Inst; 2012 Jul; 104(13):982-9. PubMed ID: 22761273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The reporting quality of randomised controlled trials in surgery: a systematic review.
    Agha R; Cooper D; Muir G
    Int J Surg; 2007 Dec; 5(6):413-22. PubMed ID: 18029237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality.
    Gomberg-Maitland M; Frison L; Halperin JL
    Am Heart J; 2003 Sep; 146(3):398-403. PubMed ID: 12947355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of reporting in surgical randomized clinical trials.
    Yu J; Li X; Li Y; Sun X
    Br J Surg; 2017 Feb; 104(3):296-303. PubMed ID: 27918069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of reporting noninferiority/similarity in research studies of diagnostic imaging.
    Park SH; Ahn S; Hong N; Park JH; Hwang SS; Lee KH
    Radiology; 2014 Jan; 270(1):241-7. PubMed ID: 24029642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Standards of reporting of randomized controlled trials in general surgery: can we do better?
    Balasubramanian SP; Wiener M; Alshameeri Z; Tiruvoipati R; Elbourne D; Reed MW
    Ann Surg; 2006 Nov; 244(5):663-7. PubMed ID: 17060756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.